| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | 1S,3R-RSL-3 | CTRPv2 | pan-cancer | AAC | 0.036 | 0.3 |
| mRNA | AA-COCF3 | CTRPv2 | pan-cancer | AAC | 0.039 | 0.3 |
| mRNA | BRD-K66453893 | CTRPv2 | pan-cancer | AAC | 0.034 | 0.3 |
| mRNA | I-BET-762 | GDSC1000 | pan-cancer | AAC | 0.031 | 0.3 |
| mRNA | Tamoxifen | GDSC1000 | pan-cancer | AAC | -0.038 | 0.3 |
| mRNA | JQ-1:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.035 | 0.3 |
| mRNA | GDC-0449 | GDSC1000 | pan-cancer | AAC | -0.04 | 0.3 |
| mRNA | TL-2-105 | GDSC1000 | pan-cancer | AAC | -0.036 | 0.3 |
| mRNA | YL54 | CTRPv2 | pan-cancer | AAC | 0.042 | 0.3 |
| mRNA | BRD-K48334597 | CTRPv2 | pan-cancer | AAC | -0.073 | 0.3 |